Vasoactive mediators and hypotensive transfusion reactions

Transfusion

Volumn 47, Issue 3, 2007, Pages 369-372

  Eastlund, Ted ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANAPHYLAXIS; ANTIBODY SCREENING; ARTERIAL PRESSURE; BLOOD CLOTTING; BLOOD TRANSFUSION REACTION; DIALYSIS; EDITORIAL; EXTRACORPOREAL CIRCULATION; FIBRINOLYSIS; HEART ARREST; HUMAN; HYPOTENSION; LEUKOCYTE; LUNG DISEASE; PATHOPHYSIOLOGY; THROMBOCYTE TRANSFUSION; VASODILATATION;

ANAPHYLAXIS; BLOOD PRESERVATION; BLOOD SPECIMEN COLLECTION; BLOOD TRANSFUSION; HUMANS; VASOCONSTRICTOR AGENTS;

EID: 33847060763     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01154.x     Document Type: Editorial

References (38)

1. Sandler SG, Mallory D, Malamut D, Eckrich R. IgA anaphylactic transfusion reactions. Transfus Med Rev 1995;9:1-8.
2. Gilstad CW. Anaphylactic transfusion reactions. Curr Opin Hematol 2003;10:419-23.
3. Sandler SG. How I manage patients suspected of having had an IgA anaphylactic transfusion reaction. Transfusion 2006;46:10-3.
4. Morishita K, Shimada E, Watanabe Y, Kimura H. Anaphylactic transfusion reactions associated with antihaptoglobin in a patient with ahaptoglobinemia. Transfusion 2000;40:120-1.
5. Koda Y, Watanabe Y, Soejima M, et al. Simple PCR detection of haptoglobin gene deletion in anhaptoglobinemic patients with antihaptoglobin antibody that causes anaphylactic transfusion reactions. Blood 2000;95:1138-43.
6. Nishiki S, Hino M, Kumura T, et al. Effectiveness of washed platelet concentrate and red cell transfusions for a patient with anhaptoglobinemia with antihaptoglobin antibody. Transfus Med 2002;12:71-3.
7. Shimada E, Tadokoro K, Watanabe Y, et al. Anaphylactic transfusion reactions in haptoglobin-deficient patients with IgE and IgG haptoglobin antibodies. Transfusion 2002;42:766-73.
8. Shimode N, Yasuoka H, Kinoshita M, et al. Severe anaphylaxis after albumin infusion in a patient with ahaptoglobinemia. Anesthesiology 2006;105:425-6.
9. Lambin P, Le Pennec PY, Hauptmann G, et al. Adverse transfusion reactions associated with a precipitating anti-C4 antibody of anti-Rodgers specificity. Vox Sang 1984;47:242-9.
10. Wibaut B, Mannessier L, Horbez C, et al. Anaphylactic reactions associated with anti-Chido antibody following platelet transfusions. Vox Sang 1995;69:150-1.
11. Heddle NM, Klama L, Singer J, et al. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994;331:625-8.
12. Muylle L. The role of cytokines in blood transfusion reactions. Blood Rev 1995;9:77-83.
13. Phipps RP, Kaufman J, Blumberg N. Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion. Lancet 2001;357:2023-4.
14. Covin RB, Ambruso DR, England KM, et al. Hypotension and acute pulmonary insufficiency following transfusion of autologous red blood cells during surgery: a case report and review of the literature. Transfus Med 2004;14:375-83.
15. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood 2005;105:2266-73.
16. Cognasse F, Boussoulade F, Chavarin P, et al. Release of potential immunomodulatory factors during platelet storage. Transfusion 2006;46:1184-9.
17. Blumberg N, Gettings KF, Turner C, Heal JM, Phipps RP. An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion 2006;46:1813-21.
18. Khan SY, Kelher MR, Heal JM, et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006;108:2455-62.
19. Fried MR, Eastlund T, Christie B, Mullin GT, Key NS. Hypotensive reactions to white cell-reduced plasma in a patient undergoing angiotensin-converting enzyme inhibitor therapy. Transfusion 1996;36:900-3.
20. Hume HA, Popovsky MA, Benson K, et al. Hypotensive reactions: a previously uncharacterized complication of platelet transfusion? Transfusion 1996;36:904-9.
21. Mair B, Leparc GF. Hypotensive reactions associated with platelet transfusions and angiotensin-converting enzyme inhibitors. Vox Sang 1998;74:27-30.
22. Shiba M, Tadokoro K, Sawanobori M, et al. Activation of the contact system by filtration of platelet concentrates with a negatively charged white cell-removal filter and measurement of venous blood bradykinin level in patients who received filtered platelets. Transfusion 1997;37:457-62.
23. Abe H, Ikebuchi K, Shimbo M, Sekiguchi S. Hypotensive reactions with a white cell-reduction filter: activation of kallikrein-kinin cascade in a patient. Transfusion 1998;38:411-2.
24. 9-bradykinin metabolism associated with severe hypotensive reactions during blood transfusions: a preliminary study. Transfusion 1999;39:1084-8.
25. Cyr M, Eastlund T, Blais C Jr, Rouleau JL, Adam A. Bradykinin metabolism and hypotensive transfusion reactions. Transfusion 2001;41:136-50.
26. Cyr M, Lepage Y, Blais C Jr, et al. Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma. Am J Physiol Heart Circ Physiol 2001;281:H275-83.
27. 9-bradykinin after contact activation. Transfusion 2002;42:1458-65.
28. Molinaro G, Duan QL, Chagnon M, et al. Kinin-dependent hypersensitivity reactions: metabolic and genetic factors. Kidney Int 2006;70:1-9.
29. Duan QL, Nikpoor B, Dube MP, et al. A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. Am J Hum Genet 2005;7:617-26.
30. Alving BM, Hojima Y, Pisano JJ, et al. Hypotension associated with prekallikrein activator (Hageman-factor fragments) in plasma protein fraction. N Engl J Med 1978;299:66-70.
31. Moreau ME, Garbacki N, Molinaro G, et al. The kallikreinkinin system: current and future pharmacological targets. J Pharmacol Sci 2005;99:6-38.
32. Yenicesu I, Tezcan I, Tuncer AM. Hypotensive reactions during platelet transfusions. Transfusion 1998;38:410.
33. Arnold DM, Molinaro G, Warkentin TE, et al. Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storage. Transfusion 2004;44:1361-6.
34. Moreau ME, Thibault L, Desormeaux A, et al. Generation of kinins during preparation and storage of whole blood-derived platelet concentrates. Transfusion 2007;47:410-20.
35. Blomback M, Chmielewska J, Netre C, Akerblom O. Activation of blood coagulation, fibrinolytic and kallikrein systems during storage of plasma. Vox Sang 1984;47:355-42.
36. Gyongyossy-Issa MI, Black T, Devine DV. Coagulation factor activation in stored platelet concentrates is modulated by the platelets. Vox Sang 1996;70:76-85.
37. Hyllner M, Tylman M, Bengtson JP, Rydberg L, Bengtsson A. Complement activation in prestorage leucocyte-filtered plasma. Transfus Med 2004;14:45-52.
38. Molinaro G, Gervais N, Adam A. Biochemical basis of angioedema associated with recombinant tissue plasminogen activator treatment: an in vitro experimental approach. Stroke 2002;33:1712-6.